Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elobixibat in Chronic Idiopathic Constipation
NCT01007123Phase 2Completed
- Sponsor
- Albireo Pharma
- Start
- Nov 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of elobixibat in chronic idiopathic constipation (CIC), sponsored by Albireo Pharma. Started Nov 2009; status: completed.
02
Drugs
elobixibat
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT01007123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007123.